Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 4, 2018
A case of immune-mediated encephalitis related to daclizumab therapyMichael Devlin, Andrew Swayne, Martin Newman, et al.Frontiers in Neurology|March 11, 2021
An Australian State-Based Cohort Study of Autoimmune Encephalitis Cases Detailing Clinical Presentation, Investigation Results, and Response to TherapyAndrew Swayne, Nicola Warren, Kerri Prain, et al.Frontiers in Neurology|April 1, 2021
Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell TherapyZara A Ioannides, Peter A Csurhes, Nanette L Douglas, et al.JCI Insight|November 16, 2018
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosisMichael P Pender, Peter A Csurhes, Corey Smith, et al.The Journal of Infection|August 8, 2025
Clinical phenotype and outcomes in autoimmune encephalitis after herpes simplex virus encephalitis: A systematic review and meta-analysisJonathan Cleaver, Renetta Chungath, Amy Gimson, et al.Brain Communications|June 19, 2026
Acute and longitudinal magnetic resonance imaging abnormalities in antibody-mediated encephalitisNabil Seery, Paul Beech, Robb Wesselingh, et al.Journal of Neurology|April 25, 2025
Multimodal prognostication of autoimmune encephalitis: an Australian autoimmune encephalitis consortium studyNabil Seery, Robb Wesselingh, Paul Beech, et al.Neurology(R) Neuroimmunology & Neuroinflammation|May 30, 2025
Rituximab Use for Relapse Prevention in Anti-NMDAR Antibody-Mediated Encephalitis: A Multicenter Cohort StudyNabil Seery, Robb Wesselingh, Paul Beech, et al.Neurology(R) Neuroimmunology & Neuroinflammation|June 19, 2025
Acute and Long-Term Immune-Treatment Strategies in Anti-LGI1 Antibody-Mediated Encephalitis: A Multicenter Cohort StudyNabil Seery, Robb Wesselingh, Paul Beech, et al.Pageof 2